Skip to main content
Fig. 2 | Cancer Imaging

Fig. 2

From: Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation

Fig. 2

Superiority of EOB-MRI compared to CECT in detecting HCC. In a 68-year-old male, EOB-MRI shows a 10-mm arterial phase hyperenhancing HCC (arrow, a) in segment 8 with nonperipheral washout (arrow, b) and obvious hypointensity on HBP (arrow, c) in keeping with LR5. However, the lesion was invisible on all phases of CECT (d-f). An additional 8-mm arterial hyperenhancing lesion is seen adjacent to the inferior vena cava (hollow arrow, a) without venous washout. Considering HBP hypointensity (hollow arrow, c), it was categorized as LR-4. Again, the lesion was invisible on CECT. Histopathologic examination of liver explant confirmed HCC at both these locations. Abbreviations: CECT: contrast-enhanced computed tomography, EOB-MRI: Gadoxetate-enhanced-MRI, HCC: hepatocellular carcinoma, HBP: hepatobiliary phase

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us